在SOD1KO小鼠模型中的AAV1.NT-3基因疗法加速的萨尔科佩尼亚
Lingying Tong1, Burcak Ozes1, Kyle Moss1
1Center for Gene Therapy, The Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH, USA.
Journal of cachexia, sarcopenia and muscle
|August 8, 2023
概括
在加速衰老的小鼠模型中,神经营养素-3 (NT-3) 基因疗法改善了身体功能和肌肉健康. 这种疗法显示出治疗老年人与年龄相关的肌肉损失的潜力.
科学领域:
- 老年学是一门学科.
- 分子生物学分子生物学
- 神经科学是一个神经科学.
背景情况:
- 随着年龄的增长而导致的肌肉质量损失 - - 萨尔科佩尼亚 - - 对老年人的健康有重大影响.
- 在SOD1KO小鼠模型中,由于Cu/Zn超氧化物脱酶缺乏,表现出加速衰老.
- 以前的研究表明NT-3激活mTOR通路,可能减轻与年龄相关的肌肉衰退.
研究的目的:
- 在加速衰老小鼠模型 (SOD1KO) 中评估携带NT-3 (AAV1.NT-3) 的腺相关病毒血清型1的治疗疗效.
主要方法:
- SOD1KO小鼠接受了肌内AAV1.NT-3注射或作为对照.
- 功能性评估包括跑步机,旋转杆和步态分析.
- 组织学和分子分析检查了肌肉纤维特征,髓化和关键路径标记 (mTOR,糖解,线粒体).
主要成果:
- 在SOD1KO小鼠中,AAV1.NT-3治疗显著改善了耐力和运动协调.
- 组织学分析显示,在接受治疗的小鼠中,肌肉纤维大小正常化,并逆转了低髓化.
- 分子分析证实了mTORC1和糖解路径的激活,与功能改善相关.
结论:
- AAV1.NT-3基因疗法有效地保护了SOD1KO小鼠免受加速衰老的影响,无论是功能还是组织学.
- NT-3显示了激活肌肉mTOR和糖解路径的潜力,这表明了与年龄相关的肌肉功能障碍的治疗策略.
相关概念视频
Satellite Stem Cells and Muscular Dystrophy
2.0K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.0K
Gene Therapy
25.5K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.5K


